FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1463-1466 June 1, 1995 Number 22 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background The extent of serious complications in people who have acquired chronic hepatitis C after a blood transfusion is unclear.

Methods We studied 131 patients with chronic post-transfusion hepatitis C who were referred to our center between February 1980 and June 1994. Eighty-two other patients were excluded because they had multiple transfusions, hemophilia, intravenous drug use, human immunodeficiency virus infection, hepatitis B infection, hemochromatosis, or alcoholic liver disease. Liver biopsies were performed in 101 patients; biopsies were not performed in the other 30 patients, all with signs of cirrhosis, because the results of coagulation tests were abnormal.

Results The mean age of the patients was 57 years (range, 21 to 81) at the time of our initial evaluation. The mean age at the time of the blood transfusion was 35 years (range, 1 to 76). The mean duration of follow-up after presentation to us was 3.9 years (range, 1 to 15). Eighty-eight of the patients (67.2 percent) initially had fatigue, and 89 (67.9 percent) had hepatomegaly. Twenty-seven patients (20.6 percent) initially had chronic hepatitis, 30 (22.9 percent) had chronic active hepatitis, 67 (51.1 percent) had cirrhosis, and 7 (5.3 percent) had hepatocellular carcinoma. Hepatocellular carcinoma developed in an additional seven patients an average of 36 months (range, 7 to 121) after the initial visit. During follow-up, 20 patients (15.3 percent) died: 8 from complications of cirrhosis (1 after a liver transplantation); 11 from hepatocellular carcinoma; and 1, with chronic active hepatitis, from pneumonia.

Conclusions In a group of patients seen at a referral center, chronic post-transfusion hepatitis C was a progressive disease and, in some patients, led to death from either liver failure or hepatocellular carcinoma.

Source Information

From the Liver Center, Huntington Memorial Hospital, 744 Fairmount Ave., Pasadena, CA 91105, where reprint requests should be addressed to Dr. Tong.

Full Text of this Article

Related Letters:

Discordant Manifestations of Hepatitis C in Monozygotic Twins
Vento S., Guella L., Concia E.
Extract | Full Text  
N Engl J Med 1995; 333:1224-1225, Nov 2, 1995. Correspondence

This article has been cited by other articles:

• Bjorkstrom, N. K., Gonzalez, V. D., Malmberg, K.-J., Falconer, K., Alaeus, A., Nowak, G., Jorns, C., Ericzon, B.-G., Weiland, O., Sandberg, J. K., Ljunggren, H.-G. (2008). Elevated Numbers of Fc{gamma}RIIIA+ (CD16+) Effector CD8 T Cells with NK Cell-Like Function in Chronic Hepatitis C Virus Infection. J. Immunol. 181: 4219-4228 [Abstract] [Full Text]  
• Murray, E, Jones, D (2008). Audit into blood-borne virus services in Her Majesty's Prison Service. Int J STD AIDS 19: 347-348 [Abstract] [Full Text]  
• Guiltinan, A. M., Kaidarova, Z., Custer, B., Orland, J., Strollo, A., Cyrus, S., Busch, M. P., Murphy, E. L. (2008). Increased All-Cause, Liver, and Cardiac Mortality among Hepatitis C Virus-seropositive Blood Donors. Am J Epidemiol 167: 743-750 [Abstract] [Full Text]  
• Castellano-Higuera, A., Gonzalez-Reimers, E., Aleman-Valls, M. R., Abreu-Gonzalez, P., Santolaria-Fernandez, F., Vega-Prieto, M. J. D. L., Gomez-Sirvent, J. L., Pelazas-Gonzalez, R. (2008). Cytokines and lipid peroxidation in alcoholics with chronic hepatitis C virus infection. Alcohol Alcohol 43: 137-142 [Abstract] [Full Text]  
• Murakami, E., Niu, C., Bao, H., Micolochick Steuer, H. M., Whitaker, T., Nachman, T., Sofia, M. A., Wang, P., Otto, M. J., Furman, P. A. (2008). The Mechanism of Action of {beta}-D-2'-Deoxy-2'-Fluoro-2'-C-Methylcytidine Involves a Second Metabolic Pathway Leading to {beta}-D-2'-Deoxy-2'-Fluoro-2'-C-Methyluridine 5'-Triphosphate, a Potent Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Antimicrob. Agents Chemother. 52: 458-464 [Abstract] [Full Text]  
• Zinkin, N. T., Grall, F., Bhaskar, K., Otu, H. H., Spentzos, D., Kalmowitz, B., Wells, M., Guerrero, M., Asara, J. M., Libermann, T. A., Afdhal, N. H. (2008). Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver Disease. Clin. Cancer Res. 14: 470-477 [Abstract] [Full Text]  
• Koretz, R. L. (2007). Considerations of Study Design. Nutr Clin Pract 22: 593-598 [Abstract] [Full Text]  
• Wang, X.-H., Netski, D. M., Astemborski, J., Mehta, S. H., Torbenson, M. S., Thomas, D. L., Ray, S. C. (2007). Progression of Fibrosis during Chronic Hepatitis C Is Associated with Rapid Virus Evolution. J. Virol. 81: 6513-6522 [Abstract] [Full Text]  
• Yano, M., Ikeda, M., Abe, K.-i., Dansako, H., Ohkoshi, S., Aoyagi, Y., Kato, N. (2007). Comprehensive Analysis of the Effects of Ordinary Nutrients on Hepatitis C Virus RNA Replication in Cell Culture. Antimicrob. Agents Chemother. 51: 2016-2027 [Abstract] [Full Text]  
• Butt, A. A, Justice, A. C, Skanderson, M., Rigsby, M. O, Good, C. B, Kwoh, C K. (2007). Rate and predictors of treatment prescription for hepatitis C. Gut 56: 385-389 [Abstract] [Full Text]  
• Saito, H., Tada, S., Ebinuma, H., Ishii, H., Kashiwazaki, K., Takahashi, M., Tsukada, N., Nishida, J., Tanaka, S., Shiozaki, H., Hibi, T. (2006). Role of erythrocytes as a reservoir for ribavirin and relationship with adverse reactions in the early phase of interferon combination therapy for chronic hepatitis C virus infections.. J. Clin. Microbiol. 44: 3562-3568 [Abstract] [Full Text]  
• Nomura-Takigawa, Y., Nagano-Fujii, M., Deng, L., Kitazawa, S., Ishido, S., Sada, K., Hotta, H. (2006). Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis. J. Gen. Virol. 87: 1935-1945 [Abstract] [Full Text]  
• Conrad, S., Garrett, L.E., Cooksley, W.G.E., Dunne, M.P., Macdonald, G.A. (2006). Living with chronic hepatitis C means `you just haven't got a normal life any more'. Chronic Illness 2: 121-131 [Abstract]  
• Balasubramanian, A., Munshi, N., Koziel, M. J., Hu, Z., Liang, T. J., Groopman, J. E., Ganju, R. K. (2005). Structural proteins of Hepatitis C virus induce interleukin 8 production and apoptosis in human endothelial cells. J. Gen. Virol. 86: 3291-3301 [Abstract] [Full Text]  
• Schmid, M, Kreil, A, Jessner, W, Homoncik, M, Datz, C, Gangl, A, Ferenci, P, Peck-Radosavljevic, M (2005). Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon {alpha} mono and combination therapy regimens. Gut 54: 1014-1020 [Abstract] [Full Text]  
• Papakonstantinou, O., Maris, T. G., Kostaridou, S., Ladis, V., Vasiliadou, A., Gourtsoyiannis, N. C. (2005). Abdominal Lymphadenopathy in {beta}-Thalassemia: MRI Features and Correlation with Liver Iron Overload and Posttransfusion Chronic Hepatitis C. Am. J. Roentgenol. 185: 219-224 [Abstract] [Full Text]  
• Cox, A. L., Mosbruger, T., Mao, Q., Liu, Z., Wang, X.-H., Yang, H.-C., Sidney, J., Sette, A., Pardoll, D., Thomas, D. L., Ray, S. C. (2005). Cellular immune selection with hepatitis C virus persistence in humans. JEM 201: 1741-1752 [Abstract] [Full Text]  
• Arenas, M. D., Sanchez-Paya, J., Barril, G., Garcia-Valdecasas, J., Gorriz, J. L., Soriano, A., Antolin, A., Lacueva, J., Garcia, S., Sirvent, A., Espinosa, M., Angoso, M. (2005). A multicentric survey of the practice of hand hygiene in haemodialysis units: factors affecting compliance. Nephrol Dial Transplant 20: 1164-1171 [Abstract] [Full Text]  
• Rumi, M G, De Filippi, F, La Vecchia, C, Donato, M F, Gallus, S, Del Ninno, E, Colombo, M (2005). Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients. Gut 54: 402-406 [Abstract] [Full Text]  
• Shiratori, Y., Ito, Y., Yokosuka, O., Imazeki, F., Nakata, R., Tanaka, N., Arakawa, Y., Hashimoto, E., Hirota, K., Yoshida, H., Ohashi, Y., Omata, M., for the Tokyo-Chiba Hepatitis Research Group*, (2005). Antiviral Therapy for Cirrhotic Hepatitis C: Association with Reduced Hepatocellular Carcinoma Development and Improved Survival. ANN INTERN MED 142: 105-114 [Abstract] [Full Text]  
• Kato, T., Date, T., Miyamoto, M., Zhao, Z., Mizokami, M., Wakita, T. (2005). Nonhepatic Cell Lines HeLa and 293 Support Efficient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon. J. Virol. 79: 592-596 [Abstract] [Full Text]  
• Li, Y., Zhang, T., Ho, C., Orange, J. S., Douglas, S. D., Ho, W.-Z. (2004). Natural killer cells inhibit hepatitis C virus expression. J. Leukoc. Biol. 76: 1171-1179 [Abstract] [Full Text]  
• Spada, E, Mele, A, Berton, A, Ruggeri, L, Ferrigno, L, Garbuglia, A R, Perrone, M P, Girelli, G, Del Porto, P, Piccolella, E, Mondelli, M U, Amoroso, P, Cortese, R, Nicosia, A, Vitelli, A, Folgori, A, on behalf of the Acute Hepatitis C Italian Study G, (2004). Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut 53: 1673-1681 [Abstract] [Full Text]  
• Salomon, J. A, Weinstein, M. C, Goldie, S. J (2004). Taking account of future technology in cost effectiveness analysis. BMJ 329: 733-736 [Full Text]  
• Liu, Z., Netski, D. M., Mao, Q., Laeyendecker, O., Ticehurst, J. R., Wang, X.-H., Thomas, D. L., Ray, S. C. (2004). Accurate Representation of the Hepatitis C Virus Quasispecies in 5.2-Kilobase Amplicons. J. Clin. Microbiol. 42: 4223-4229 [Abstract] [Full Text]  
• Matthews, J. D., Bini, E. J. (2004). Epidemiology, Diagnosis, and Treatment of Chronic Hepatitis C. Journal of Pharmacy Practice 17: 229-238 [Abstract]  
• d'Souza, R.F.C., Glynn, M.J., Alstead, E., Osonayo, C., Foster, G.R. (2004). Knowledge of chronic hepatitis C among East London primary care physicians following the Department of Health's educational campaign. QJM 97: 331-336 [Abstract] [Full Text]  
• Date, T., Kato, T., Miyamoto, M., Zhao, Z., Yasui, K., Mizokami, M., Wakita, T. (2004). Genotype 2a Hepatitis C Virus Subgenomic Replicon Can Replicate in HepG2 and IMY-N9 Cells. J. Biol. Chem. 279: 22371-22376 [Abstract] [Full Text]  
• Netski, D. M., Wang, X.-H., Mehta, S. H., Nelson, K., Celentano, D., Thongsawat, S., Maneekarn, N., Suriyanon, V., Jittiwutikorn, J., Thomas, D. L., Ticehurst, J. R. (2004). Hepatitis C Virus (HCV) Core Antigen Assay To Detect Ongoing HCV Infection in Thai Injection Drug Users. J. Clin. Microbiol. 42: 1631-1636 [Abstract] [Full Text]  
• Krahn, M., Wong, J. B., Heathcote, J., Scully, L., Seeff, L. (2004). Estimating the Prognosis of Hepatitis C Patients Infected by Transfusion in Canada between 1986 and 1990. Med Decis Making 24: 20-29 [Abstract]  
• Harvey, C. E., Post, J. J., Palladinetti, P., Freeman, A. J., Ffrench, R. A., Kumar, R. K., Marinos, G., Lloyd, A. R. (2003). Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J. Leukoc. Biol. 74: 360-369 [Abstract] [Full Text]  
• Li, Y., Zhang, T., Douglas, S. D., Lai, J.-P., Xiao, W.-D., Pleasure, D. E., Ho, W.-Z. (2003). Morphine Enhances Hepatitis C Virus (HCV) Replicon Expression. Am. J. Pathol. 163: 1167-1175 [Abstract] [Full Text]  
• Salomon, J. A., Weinstein, M. C., Hammitt, J. K., Goldie, S. J. (2003). Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population. JAMA 290: 228-237 [Abstract] [Full Text]  
• Gupta, S., Bent, S., Kohlwes, J. (2003). Test Characteristics of {alpha}-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C: A Systematic Review and Critical Analysis. ANN INTERN MED 139: 46-50 [Abstract] [Full Text]  
• Flamm, S. L. (2003). Chronic Hepatitis C Virus Infection. JAMA 289: 2413-2417 [Full Text]  
• Wright, M, Goldin, R, Fabre, A, Lloyd, J, Thomas, H, Trepo, C, Pradat, P, Thursz, M (2003). Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut 52: 574-579 [Abstract] [Full Text]  
• Carroll, S. S., Tomassini, J. E., Bosserman, M., Getty, K., Stahlhut, M. W., Eldrup, A. B., Bhat, B., Hall, D., Simcoe, A. L., LaFemina, R., Rutkowski, C. A., Wolanski, B., Yang, Z., Migliaccio, G., De Francesco, R., Kuo, L. C., MacCoss, M., Olsen, D. B. (2003). Inhibition of Hepatitis C Virus RNA Replication by 2'-Modified Nucleoside Analogs. J. Biol. Chem. 278: 11979-11984 [Abstract] [Full Text]  
• Papatheodoridis, G V, Papakonstantinou, E, Andrioti, E, Cholongitas, E, Petraki, K, Kontopoulou, I, Hadziyannis, S J (2003). Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut 52: 404-409 [Abstract] [Full Text]  
• Sulkowski, M. S., Thomas, D. L. (2003). Hepatitis C in the HIV-Infected Person. ANN INTERN MED 138: 197-207 [Abstract] [Full Text]  
• Castera, L, Hezode, C, Roudot-Thoraval, F, Bastie, A, Zafrani, E-S, Pawlotsky, J-M, Dhumeaux, D (2003). Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 52: 288-292 [Abstract] [Full Text]  
• Hezode, C, Lonjon, I, Roudot-Thoraval, F, Mavier, J-P, Pawlotsky, J-M, Zafrani, E S, Dhumeaux, D (2003). Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 52: 126-129 [Abstract] [Full Text]  
• Kuehne, F. C., Bethe, U., Freedberg, K., Goldie, S. J. (2002). Treatment for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Patients: Clinical Benefits and Cost-effectiveness. Arch Intern Med 162: 2545-2556 [Abstract] [Full Text]  
• Salomon, J. A., Weinstein, M. C., Hammitt, J. K., Goldie, S. J. (2002). Empirically Calibrated Model of Hepatitis C Virus Infection in the United States. Am J Epidemiol 156: 761-773 [Abstract] [Full Text]  
• Piche, T, Gelsi, E, Schneider, S M, Hebuterne, X, Giudicelli, J, Ferrua, B, Laffont, C, Benzaken, S, Hastier, P, Montoya, M L, Longo, F, Rampal, P, Tran, A (2002). Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut 51: 434-439 [Abstract] [Full Text]  
• Goedert, J. J., Eyster, M. E., Lederman, M. M., Mandalaki, T., de Moerloose, P., White, G. C. II, Angiolillo, A. L., Luban, N. L. C., Sherman, K. E., Manco-Johnson, M., Preiss, L., Leissinger, C., Kessler, C. M., Cohen, A. R., DiMichele, D., Hilgartner, M. W., Aledort, L. M., Kroner, B. L., Rosenberg, P. S., Hatzakis, A. (2002). End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 100: 1584-1589 [Abstract] [Full Text]  
• Codispoti, M., Mankad, P.S. (2002). Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: randomised controlled trial. Eur. J. Cardiothorac. Surg. 22: 200-205 [Abstract] [Full Text]  
• Minola, E., Prati, D., Suter, F., Maggiolo, F., Caprioli, F., Sonzogni, A., Fraquelli, M., Paggi, S., Conte, D. (2002). Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 99: 4588-4591 [Abstract] [Full Text]  
• Herrine, S. K. (2002). Approach to the Patient with Chronic Hepatitis C Virus Infection. ANN INTERN MED 136: 747-757 [Abstract] [Full Text]  
• Harris, H. E, Ramsay, M. E, Andrews, N., Eldridge, K. P (2002). Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ 324: 450-450 [Abstract] [Full Text]  
• Wellnitz, S., Klumpp, B., Barth, H., Ito, S., Depla, E., Dubuisson, J., Blum, H. E., Baumert, T. F. (2002). Binding of Hepatitis C Virus-Like Particles Derived from Infectious Clone H77C to Defined Human Cell Lines. J. Virol. 76: 1181-1193 [Abstract] [Full Text]  
• Franchini, M., Rossetti, G., Tagliaferri, A., Capra, F., de Maria, E., Pattacini, C., Lippi, G., Lo Cascio, G., de Gironcoli, M., Gandini, G. (2001). The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. Blood 98: 1836-1841 [Abstract] [Full Text]  
• Tai, C.-L., Pan, W.-C., Liaw, S.-H., Yang, U.-C., Hwang, L.-H., Chen, D.-S. (2001). Structure-Based Mutational Analysis of the Hepatitis C Virus NS3 Helicase. J. Virol. 75: 8289-8297 [Abstract] [Full Text]  
• Barrett, S, Goh, J, Coughlan, B, Ryan, E, Stewart, S, Cockram, A, O'Keane, J C, Crowe, J (2001). The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 49: 423-430 [Abstract] [Full Text]  
• Espinosa, M., Martin-Malo, A., de Lara, M. A. A., Aljama, P. (2001). Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients. Nephrol Dial Transplant 16: 1669-1674 [Abstract] [Full Text]  
• Kelley, V. A., Caliendo, A. M. (2001). Successful Testing Protocols in Virology. Clin. Chem. 47: 1559-1562 [Abstract] [Full Text]  
• Walsh, K, Alexander, G J M (2001). Update on chronic viral hepatitis. Postgrad. Med. J. 77: 498-505 [Abstract] [Full Text]  
• Booth, J C L, O'Grady, J, Neuberger, J (2001). Clinical guidelines on the management of hepatitis C. Gut 49: I1-21 [Full Text]  
• Mohsen, A H, Group, T. H. S. (2001). The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut 48: 707-713 [Abstract] [Full Text]  
• Tillmann, H L, Chen, D-F, Trautwein, C, Kliem, V, Grundey, A, Berning-Haag, A, Boker, K, Kubicka, S, Pastucha, L, Stangel, W, Manns, M P (2001). Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut 48: 714-718 [Abstract] [Full Text]  
• Hyams, K. C., Riddle, J., Rubertone, M., Trump, D., Alter, M. J., Cruess, D. F., Han, X., Nainam, O. V., Seeff, L. B., Mazzuchi, J. F., Bailey, S. (2001). Prevalence and Incidence of Hepatitis C Virus Infection in the US Military: A Seroepidemiologic Survey of 21,000 Troops. Am J Epidemiol 153: 764-770 [Abstract] [Full Text]  
• Jowett, S.L., Agarwal, K., Smith, B.C., Craig, W., Hewett, M., Bassendine, D.R., Gilvarry, E., Burt, A.D., Bassendine, M.F. (2001). Managing chronic hepatitis C acquired through intravenous drug use. QJM 94: 153-158 [Abstract] [Full Text]  
• Jacobson, J. M., Feinman, L., Liebes, L., Ostrow, N., Koslowski, V., Tobia, A., Cabana, B. E., Lee, D.-H., Spritzler, J., Prince, A. M. (2001). Pharmacokinetics, Safety, and Antiviral Effects of Hypericin, a Derivative of St. John's Wort Plant, in Patients with Chronic Hepatitis C Virus Infection. Antimicrob. Agents Chemother. 45: 517-524 [Abstract] [Full Text]  
• Cummings, K. J., Lee, S. M., West, E. S., Cid-Ruzafa, J., Fein, S. G., Aoki, Y., Sulkowski, M. S., Goodman, S. N. (2001). Interferon and Ribavirin vs Interferon Alone in the Re-treatment of Chronic Hepatitis C Previously Nonresponsive to Interferon: A Meta-analysis of Randomized Trials. JAMA 285: 193-199 [Abstract] [Full Text]  
• Bonacini, M., Puoti, M. (2000). Hepatitis C in Patients With Human Immunodeficiency Virus Infection: Diagnosis, Natural History, Meta-analysis of Sexual and Vertical Transmission, and Therapeutic Issues. Arch Intern Med 160: 3365-3373 [Abstract] [Full Text]  
• Wünschmann, S., Medh, J. D., Klinzmann, D., Schmidt, W. N., Stapleton, J. T. (2000). Characterization of Hepatitis C Virus (HCV) and HCV E2 Interactions with CD81 and the Low-Density Lipoprotein Receptor. J. Virol. 74: 10055-10062 [Abstract] [Full Text]  
• Mehta, S. H., Brancati, F. L., Sulkowski, M. S., Strathdee, S. A., Szklo, M., Thomas, D. L. (2000). Prevalence of Type 2 Diabetes Mellitus among Persons with Hepatitis C Virus Infection in the United States. ANN INTERN MED 133: 592-599 [Abstract] [Full Text]  
• Foster, G R, Chapman, R (2000). Combination treatment for hepatitis C is not being given. BMJ 321: 899a-899 [Full Text]  
• Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., Laeyendecker, O., Boitnott, J., Wilson, L. E., Vlahov, D. (2000). The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors. JAMA 284: 450-456 [Abstract] [Full Text]  
• Degos, F, Christidis, C, Ganne-Carrie, N, Farmachidi, J-P, Degott, C, Guettier, C, Trinchet, J-C, Beaugrand, M, Chevret, S (2000). Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 47: 131-136 [Abstract] [Full Text]  
• Shiratori, Y., Yoshida, H., Omata, M. (2000). Effects of Interferon Therapy on Inhibition of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis C. Jpn J Clin Oncol 30: 213-214 [Full Text]  
• Manzin, A., Solforosi, L., Debiaggi, M., Zara, F., Tanzi, E., Romanò, L., Zanetti, A. R., Clementi, M. (2000). Dominant Role of Host Selective Pressure in Driving Hepatitis C Virus Evolution in Perinatal Infection. J. Virol. 74: 4327-4334 [Abstract] [Full Text]  
• KHAN, K. N., YATSUHASHI, H. (2000). EFFECT OF ALCOHOL CONSUMPTION ON THE PROGRESSION OF HEPATITIS C VIRUS INFECTION AND RISK OF HEPATOCELLULAR CARCINOMA IN JAPANESE PATIENTS. Alcohol Alcohol 35: 286-295 [Abstract] [Full Text]  
• Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Munoz, S. J., Balestrieri, A., Purcell, R. H., Alter, H. J. (2000). The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies. Science 288: 339-344 [Abstract] [Full Text]  
• Shiratori, Y., Imazeki, F., Moriyama, M., Yano, M., Arakawa, Y., Yokosuka, O., Kuroki, T., Nishiguchi, S., Sata, M., Yamada, G., Fujiyama, S., Yoshida, H., Omata, M. (2000). Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy. ANN INTERN MED 132: 517-524 [Abstract] [Full Text]  
• Ray, S. C., Mao, Q., Lanford, R. E., Bassett, S., Laeyendecker, O., Wang, Y.-M., Thomas, D. L. (2000). Hypervariable Region 1 Sequence Stability during Hepatitis C Virus Replication in Chimpanzees. J. Virol. 74: 3058-3066 [Abstract] [Full Text]  
• Gutfreund, K. S., Bain, V. G. (2000). Chronic viral hepatitis C: management update. CMAJ 162: 827-833 [Abstract] [Full Text]  
• Liang, T. J., Rehermann, B., Seeff, L. B., Hoofnagle, J. H. (2000). Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C. ANN INTERN MED 132: 296-305 [Abstract] [Full Text]  
• Seeff, L. B., Miller, R. N., Rabkin, C. S., Buskell-Bales, Z., Straley-Eason, K. D., Smoak, B. L., Johnson, L. D., Lee, S. R., Kaplan, E. L. (2000). 45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults. ANN INTERN MED 132: 105-111 [Abstract] [Full Text]  
• Heim, M. H., Moradpour, D., Blum, H. E. (1999). Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway. J. Virol. 73: 8469-8475 [Abstract] [Full Text]  
• Vogt, M., Lang, T., Frosner, G., Klingler, C., Sendl, A. F., Zeller, A., Wiebecke, B., Langer, B., Meisner, H., Hess, J. (1999). Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery before the Implementation of Blood-Donor Screening. NEJM 341: 866-870 [Abstract] [Full Text]  
• Paul, I. M., Sanders, J., Ruggiero, F., Andrews, T., Ungar, D., Eyster, M. E. (1999). Chronic Hepatitis C Virus Infections in Leukemia Survivors: Prevalence, Viral Load, and Severity of Liver Disease. Blood 93: 3672-3677 [Abstract] [Full Text]  
• Strasser, S. I., Sullivan, K. M., Myerson, D., Spurgeon, C. L., Storer, B., Schoch, H. G., Murakami, C. S., McDonald, G. B. (1999). Cirrhosis of the Liver in Long-Term Marrow Transplant Survivors. Blood 93: 3259-3266 [Abstract] [Full Text]  
• Kenny-Walsh, E., The Irish Hepatology Research Group, (1999). Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin. NEJM 340: 1228-1233 [Abstract] [Full Text]  
• Ray, S. C., Wang, Y.-M., Laeyendecker, O., Ticehurst, J. R., Villano, S. A., Thomas, D. L. (1999). Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy. J. Virol. 73: 2938-2946 [Abstract] [Full Text]  
• Datz, C, Cramp, M, Haas, T, Dietze, O, Nitschko, H, Froesner, G, Muss, N, Sandhofer, F, Vogel, W (1999). The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre. Gut 44: 563-567 [Abstract] [Full Text]  
• Strasser, S. I., McDonald, G. B. (1999). Hepatitis Viruses and Hematopoietic Cell Transplantation: A Guide to Patient and Donor Management. Blood 93: 1127-1136 [Full Text]  
• Goodnough, L. T., Brecher, M. E., Kanter, M. H., AuBuchon, J. P. (1999). Transfusion Medicine -- Blood Transfusion- First of Two Parts. NEJM 340: 438-447 [Full Text]  
• McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., Albrecht, J. K., The Hepatitis Interventional Therapy Group, (1998). Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C. NEJM 339: 1485-1492 [Abstract] [Full Text]  
• Granovsky, M. O., Minkoff, H. L., Tess, B. H., Waters, D., Hatzakis, A., Devoid, D. E., Landesman, S. H., Rubinstein, A., Di Bisceglie, A. M., Goedert, J. J. (1998). Hepatitis C Virus Infection in the Mothers and Infants Cohort Study. Pediatrics 102: 355-359 [Abstract] [Full Text]  
• Manzin, A., Solforosi, L., Petrelli, E., Macarri, G., Tosone, G., Piazza, M., Clementi, M. (1998). Evolution of Hypervariable Region 1 of Hepatitis C Virus in Primary Infection. J. Virol. 72: 6271-6276 [Abstract] [Full Text]  
• Baumert, T. F., Ito, S., Wong, D. T., Liang, T. J. (1998). Hepatitis C Virus Structural Proteins Assemble into Viruslike Particles in Insect Cells. J. Virol. 72: 3827-3836 [Abstract] [Full Text]  
• Wong, D. K. H., Dudley, D. D., Afdhal, N. H., Dienstag, J., Rice, C. M., Wang, L., Houghton, M., Walker, B. D., Koziel, M. J. (1998). Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection. J. Immunol. 160: 1479-1488 [Abstract] [Full Text]  
• Locasciulli, A., Testa, M., Pontisso, P., Benvegnu, L., Fraschini, D., Corbetta, A., Noventa, F., Masera, G., Alberti, A. (1997). Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia. Blood 90: 4628-4633 [Abstract] [Full Text]  
• Angelucci, E., Muretto, P., Lucarelli, G., Ripalti, M., Baronciani, D., Erer, B., Galimberti, M., Giardini, C., Gaziev, D., Polchi, P., the Italian Cooperative Group for Phlebotomy Treat, (1997). Phlebotomy to Reduce Iron Overload in Patients Cured of Thalassemia by Bone Marrow Transplantation. Blood 90: 994-998 [Abstract] [Full Text]  
• Rossi, G., Tucci, A., Cariani, E., Ravaggi, A., Rossini, A., Radaeli, E. (1997). Outbreak of Hepatitis C Virus Infection in Patients With Hematologic Disorders Treated With Intravenous Immunoglobulins: Different Prognosis According to the Immune Status. Blood 90: 1309-1314 [Abstract] [Full Text]  
• Cesaro, S., Petris, M. G., Rossetti, F., Cusinato, R., Pipan, C., Guido, M., Masiero, L., Botta, G. A., Meloni, G. A., Zanesco, L. (1997). Chronic Hepatitis C Virus Infection After Treatment for Pediatric Malignancy. Blood 90: 1315-1320 [Abstract] [Full Text]  
• Olivieri, N. F., Brittenham, G. M. (1997). Iron-Chelating Therapy and the Treatment of Thalassemia. Blood 89: 739-761 [Full Text]  
• Hoofnagle, J. H., Di Bisceglie, A. M. (1997). The Treatment of Chronic Viral Hepatitis. NEJM 336: 347-356 [Full Text]